- Home
- PASG vs CARM Comparison
PASG vs CARM Comparison
Compare PASG & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- CARM
- Stock Information
- Founded
- PASG 2017
- CARM 2016
- Country
- PASG United States
- CARM United States
- Employees
- PASG N/A
- CARM N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- PASG Health Care
- CARM Health Care
- Exchange
- PASG Nasdaq
- CARM Nasdaq
- Market Cap
- PASG 42.2M
- CARM 41.5M
- IPO Year
- PASG 2020
- CARM N/A
- Fundamental
- Price
- PASG $0.52
- CARM $0.88
- Analyst Decision
- PASG Strong Buy
- CARM Strong Buy
- Analyst Count
- PASG 1
- CARM 3
- Target Price
- PASG $13.00
- CARM $12.67
- AVG Volume (30 Days)
- PASG 229.5K
- CARM 191.3K
- Earning Date
- PASG 11-13-2024
- CARM 11-07-2024
- Dividend Yield
- PASG N/A
- CARM N/A
- EPS Growth
- PASG N/A
- CARM N/A
- EPS
- PASG N/A
- CARM N/A
- Revenue
- PASG N/A
- CARM $20,268,000.00
- Revenue This Year
- PASG N/A
- CARM $50.40
- Revenue Next Year
- PASG N/A
- CARM N/A
- P/E Ratio
- PASG N/A
- CARM N/A
- Revenue Growth
- PASG N/A
- CARM 41.13
- 52 Week Low
- PASG $0.49
- CARM $0.80
- 52 Week High
- PASG $1.79
- CARM $3.16
- Technical
- Relative Strength Index (RSI)
- PASG 37.27
- CARM 34.30
- Support Level
- PASG $0.58
- CARM $0.96
- Resistance Level
- PASG $0.68
- CARM $1.01
- Average True Range (ATR)
- PASG 0.06
- CARM 0.06
- MACD
- PASG -0.01
- CARM -0.01
- Stochastic Oscillator
- PASG 13.44
- CARM 8.59
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.